148 related articles for article (PubMed ID: 26291011)
61. Micropapillary Predominance Is a Risk Factor for Brain Metastasis in Resected Lung Adenocarcinoma.
Shigenobu T; Takahashi Y; Masugi Y; Hanawa R; Matsushita H; Tajima A; Kuroda H
Clin Lung Cancer; 2021 Nov; 22(6):e820-e828. PubMed ID: 33992533
[TBL] [Abstract][Full Text] [Related]
62. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
Guo T; Zhao S; Li Z; Li F; Li J; Gu C
Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
[TBL] [Abstract][Full Text] [Related]
63. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
[TBL] [Abstract][Full Text] [Related]
64. Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patients.
Zhao X; Zhang Y; Qian K; Zhao L; Wang W; Teng LH
Thorac Cancer; 2017 Nov; 8(6):565-571. PubMed ID: 28834269
[TBL] [Abstract][Full Text] [Related]
65. Preoperative predictors of distant recurrence in patients with clinical stage IA lung adenocarcinoma undergoing complete resection.
Ibuki Y; Tsutani Y; Miyata Y; Nakayama H; Okumura S; Yoshimura M; Okada M
Jpn J Clin Oncol; 2017 Feb; 47(2):157-163. PubMed ID: 28173177
[TBL] [Abstract][Full Text] [Related]
66. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
Lee K; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Han J
Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):623-629. PubMed ID: 29058973
[TBL] [Abstract][Full Text] [Related]
67. Visceral Pleural Invasion Is a Significant Prognostic Factor in Patients with Partly Solid Lung Adenocarcinoma Sized 30 mm or Smaller.
Seok Y; Lee E
Thorac Cardiovasc Surg; 2018 Mar; 66(2):150-155. PubMed ID: 27517168
[TBL] [Abstract][Full Text] [Related]
68. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
[TBL] [Abstract][Full Text] [Related]
69. Surgically resected solitary cavitary lung adenocarcinoma: association between clinical, pathologic, and radiologic findings and prognosis.
Watanabe Y; Kusumoto M; Yoshida A; Suzuki K; Asamura H; Tsuta K
Ann Thorac Surg; 2015 Mar; 99(3):968-74. PubMed ID: 25620598
[TBL] [Abstract][Full Text] [Related]
70. Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma.
Tsubokawa N; Mimae T; Miyata Y; Sasada S; Yoshiya T; Kushitani K; Takeshima Y; Murakami S; Yokose T; Ito H; Nakayama H; Okada M
Jpn J Clin Oncol; 2016 Nov; 46(11):1015-1021. PubMed ID: 27566971
[TBL] [Abstract][Full Text] [Related]
71. Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome.
Cha MJ; Lee HY; Lee KS; Jeong JY; Han J; Shim YM; Hwang HS
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):921-928.e2. PubMed ID: 24199757
[TBL] [Abstract][Full Text] [Related]
72. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
[TBL] [Abstract][Full Text] [Related]
73. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
[TBL] [Abstract][Full Text] [Related]
74. Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: a meta-analysis.
Wang W; Hu Z; Zhao J; Huang Y; Rao S; Yang J; Xiao S; Cao R; Ye L
J Cardiothorac Surg; 2020 Jun; 15(1):154. PubMed ID: 32600473
[TBL] [Abstract][Full Text] [Related]
75. Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes.
Lee G; Lee HY; Jeong JY; Han J; Cha MJ; Lee KS; Kim J; Shim YM
Am J Surg Pathol; 2015 May; 39(5):660-6. PubMed ID: 25724001
[TBL] [Abstract][Full Text] [Related]
76. Current readings: pathology, prognosis, and lung cancer.
Suh JH
Semin Thorac Cardiovasc Surg; 2013; 25(1):14-21. PubMed ID: 23800525
[TBL] [Abstract][Full Text] [Related]
77. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
78. Prediction and prognostic factors of post-recurrence survival in recurred patients with early-stage NSCLC who underwent complete resection.
Choi PJ; Jeong SS; Yoon SS
J Thorac Dis; 2016 Jan; 8(1):152-60. PubMed ID: 26904224
[TBL] [Abstract][Full Text] [Related]
79. Spread through air spaces is a predictive factor of recurrence and a prognostic factor in stage I lung adenocarcinoma.
Shiono S; Yanagawa N
Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):567-72. PubMed ID: 27354463
[TBL] [Abstract][Full Text] [Related]
80. Prognostic factors and clinical outcome in patients with surgically resected peripheral N0 adenocarcinoma <3 cm.
Luzzi L; Marulli G; DE Palma A; Meniconi F; Ghisalberti M; Stocca F; Pagliarulo V; Loizzi M; Rea F; Gotti G
Minerva Chir; 2016 Feb; 71(1):1-7. PubMed ID: 26149520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
